Skip to content

Clinical trials

Lung Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Japan Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20142
20151
20162
20172
20192
20201
20211
20222
20233
20246
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Active, not recruiting6
Completed6
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Eli Lilly and Company4
Pfizer3
Blueprint Medicines Corporation2
Taiho Oncology, Inc.2
Upstream Bio Inc.2
GlaxoSmithKline1
Hoffmann-La Roche1
Mannkind Corporation1
Medtronic - MITG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases29
Respiratory Tract Diseases17
Carcinoma, Non-Small-Cell Lung10
Lung Neoplasms9
Carcinoma, Bronchogenic7
Neoplasms7
Neoplasms by Site7
Respiratory Tract Neoplasms7
Thoracic Neoplasms7
Asthma6

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.